📣 VC round data is live. Check it out!
- Public Comps
- Mesa Laboratories
Mesa Laboratories Valuation Multiples
Discover Mesa Laboratories' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like SD Biosensor, BrainsWay, TOKYO KEIKI, Beta Bionics and more.
Mesa Laboratories Overview
About Mesa Laboratories
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
Founded
1982
HQ

Employees
730
Website
Financials (LTM)
EV
$741M
Valuation Multiples
Start free trialMesa Laboratories Financials
Mesa Laboratories reported last 12-month revenue of $251M and EBITDA of $64M.
In the same LTM period, Mesa Laboratories generated $159M in gross profit, $64M in EBITDA, and $8M in net income.
Revenue (LTM)
Mesa Laboratories P&L
In the most recent fiscal year, Mesa Laboratories reported revenue of $241M and EBITDA of $42M.
Mesa Laboratories is unprofitable as of last fiscal year, with gross margin of 63%, EBITDA margin of 18%, and net margin of (1%).
Financial data powered by Morningstar, Inc.
Mesa Laboratories Stock Performance
Mesa Laboratories has current market cap of $589M, and enterprise value of $741M.
Market Cap Evolution
Mesa Laboratories' stock price is $106.66.
Mesa Laboratories share price increased by 4.5% in the last 30 days, and by 13.2% in the last year.
Mesa Laboratories has an EPS (earnings per share) of $-0.36.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $741M | $589M | 1.4% | 4.5% | 20.6% | 13.2% | $-0.36 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMesa Laboratories Valuation Multiples
Mesa Laboratories trades at 3.0x EV/Revenue multiple, and 11.6x EV/EBITDA.
EV / Revenue (LTM)
Mesa Laboratories Financial Valuation Multiples
As of June 4, 2026, Mesa Laboratories has market cap of $589M and EV of $741M.
Mesa Laboratories has a P/E ratio of 74.0x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Mesa Laboratories Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Mesa Laboratories Margins & Growth Rates
Mesa Laboratories grew revenue by 3% and EBITDA by 50% in the last fiscal year.
In the most recent fiscal year, Mesa Laboratories reported gross margin of 63%, EBITDA margin of 18%, and net margin of (1%).
Mesa Laboratories Margins
Mesa Laboratories Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Mesa Laboratories Operational KPIs
Mesa Laboratories' revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.2M for the same period.
Mesa Laboratories' Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mesa Laboratories' Rule of X is 35% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Mesa Laboratories Competitors
Mesa Laboratories competitors include SD Biosensor, BrainsWay, TOKYO KEIKI, Beta Bionics, Japan Lifeline, SI-BONE, NeuroPace, Sofwave Medical, Tactile Medical and Bioventus.
Most Mesa Laboratories public comparables operate across Medical Devices, Test & Measurement, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.0x | - | (1.0x) | - | |||
| 10.3x | 9.2x | 55.0x | 57.3x | |||
| 1.9x | 1.7x | 17.6x | - | |||
| 3.8x | 3.3x | (7.1x) | (5.9x) | |||
| 1.4x | 1.3x | 5.8x | 5.6x | |||
| 2.6x | 2.4x | 58.3x | 51.0x | |||
| 5.7x | 5.7x | (114.3x) | (86.6x) | |||
| 6.0x | - | 68.7x | - | |||
This data is available for Pro users. Sign up to see all Mesa Laboratories competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Mesa Laboratories
Mesa Laboratories has acquired 11 companies to date.
Last acquisition by Mesa Laboratories was on November 17th 2022. Mesa Laboratories acquired Belyntic for undisclosed valuation.
Latest Acquisitions by Mesa Laboratories
| Description | Belyntic is a Vienna-based biotech company developing synthetic long peptide vaccines for viruses like RSV and HPV. Its self-adjuvant platform has advanced candidates into Phase I trials, validated in preclinical models showing 90 percent T-cell response rates. Founded in 2020, Belyntic collaborates with universities in Austria and the U.S. | Agena Bioscience is a San Diego-headquartered molecular diagnostics provider offering the MassARRAY system for genetic analysis. This mass spectrometry platform enables high-throughput multiplexing for up to 40 markers per sample in fields like infectious disease detection, oncology profiling via solid tumors and liquid biopsies, inherited disorders, and pharmacogenetics. Deployed in over 90 countries, Agena serves clinical labs, research institutions, and agrogenomics applications with automated workflows. | Gyros Protein Technologies is a Swedish firm based in Uppsala that manufactures peptide synthesizers and high-purity reagents for solid-phase peptide synthesis. Its PurePep series instruments automate synthesis from small-scale research to multi-kilogram GMP production. The company serves pharmaceutical firms and academic labs worldwide, with systems installed in over 40 countries for drug discovery and development of peptide therapeutics. | FreshLoc Technologies is a provider of wireless temperature monitoring systems for fridges and freezers in healthcare, labs, and food processing. Its sensors alert via cloud dashboard for compliance with FDA and HACCP regulations. Headquartered in Quebec City since 2009, it serves North American clients. | |
| HQ Country | |||||
| HQ City | Berlin | San Diego, CA | Tucson, AZ | Dallas, TX | |
| Deal Date | 17 Nov 2022 | 14 Sep 2021 | 11 Nov 2019 | 7 Nov 2016 | |
| Valuation | undisclosed | $300M | $180M | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all Mesa Laboratories acquisitions and their M&A valuation multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Mesa Laboratories
| When was Mesa Laboratories founded? | Mesa Laboratories was founded in 1982. |
| Where is Mesa Laboratories headquartered? | Mesa Laboratories is headquartered in United States. |
| How many employees does Mesa Laboratories have? | As of today, Mesa Laboratories has over 730 employees. |
| Who is the CEO of Mesa Laboratories? | Mesa Laboratories' CEO is Gary M. Owens. |
| Is Mesa Laboratories publicly listed? | Yes, Mesa Laboratories is a public company listed on Nasdaq. |
| What is the stock symbol of Mesa Laboratories? | Mesa Laboratories trades under MLAB ticker. |
| When did Mesa Laboratories go public? | Mesa Laboratories went public in 1984. |
| Who are competitors of Mesa Laboratories? | Mesa Laboratories main competitors include SD Biosensor, BrainsWay, TOKYO KEIKI, Beta Bionics, Japan Lifeline, SI-BONE, NeuroPace, Sofwave Medical, Tactile Medical, Bioventus. |
| What is the current market cap of Mesa Laboratories? | Mesa Laboratories' current market cap is $589M. |
| What is the current revenue of Mesa Laboratories? | Mesa Laboratories' last 12 months revenue is $251M. |
| What is the current revenue growth of Mesa Laboratories? | Mesa Laboratories revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of Mesa Laboratories? | Current revenue multiple of Mesa Laboratories is 3.0x. |
| What is the current EBITDA of Mesa Laboratories? | Mesa Laboratories' last 12 months EBITDA is $64M. |
| What is Mesa Laboratories' EBITDA margin? | Mesa Laboratories' last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Mesa Laboratories? | Current EBITDA multiple of Mesa Laboratories is 11.6x. |
| What is the current FCF of Mesa Laboratories? | Mesa Laboratories' last 12 months FCF is $34M. |
| What is Mesa Laboratories' FCF margin? | Mesa Laboratories' last 12 months FCF margin is 14%. |
| What is the current EV/FCF multiple of Mesa Laboratories? | Current FCF multiple of Mesa Laboratories is 21.8x. |
| How many companies Mesa Laboratories has acquired to date? | As of June 2026, Mesa Laboratories has acquired 11 companies. |
| What was the largest acquisition by Mesa Laboratories? | $300M acquisition of Agena Bioscience on 14th September 2021 was the largest M&A Mesa Laboratories has done to date. |
| What companies Mesa Laboratories acquired? | Mesa Laboratories acquired Agena Bioscience, Gyros Protein Technologies, North Bay Bioscience, BGI, Inc, Infitrak, FreshLoc Technologies, Autoclave Testing Services, Belyntic, Cherwell Laboratories, Amilabo SA, and 1 other company. |
| In how many companies Mesa Laboratories has invested to date? | Mesa Laboratories hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Mesa Laboratories
Lists including Mesa Laboratories
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

